$country= Comparative statistics by cancer registry - SurvCan

Comparative statistics by cancer registry

Registry: Comparative statistics by cancer site

Table3: Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site

(Seoul, South Korea, 1993-1997 cases followed-up until 2001)

Click on cancer site (ICD-10 code) for comparison
SiteICD-10TotalAbsolute survival %Relative survival %ASRS% at 5-years
1-year3-year5-year1-year3-year5-yearall ages0-74 years
C00Lip2676.953.850.080.361.161.865.571.6
C01-02Tongue24379.059.754.480.863.761.060.859.6
C03-06Oral cavity30373.350.245.774.953.450.649.951.6
C07-08Salivary gland19489.270.664.390.473.668.762.764.4
C09Tonsil9277.256.551.978.659.656.655.058.3
C10Other oropharynx5267.340.432.768.942.835.737.042.8
C11Nasopharynx27881.752.543.782.754.446.341.347.1
C12-13Hypopharynx17056.528.225.158.030.729.331.331.3
C15Oesophagus113442.320.416.843.622.119.220.022.8
C16Stomach1618064.247.342.965.650.247.643.349.2
C17Small intestine24255.436.430.056.538.332.829.634.5
C18Colon372077.162.256.878.966.764.159.865.7
C19-20Rectum371582.561.854.384.265.860.657.561.5
C21Anus31356.234.228.057.837.332.431.533.8
C22Liver987238.721.917.539.423.119.218.920.3
C23-24Gall bladder229344.327.323.045.529.526.427.930.3
C25Pancreas180726.114.413.126.815.615.015.617.1
C26Gastrointestinal tract unspecified5841.427.622.342.730.326.226.227.0
C30-31Nose/Sinuses22474.154.045.975.356.950.453.150.9
C32Larynx79183.165.761.585.571.871.871.075.6
C33-34Lung848240.218.615.941.420.318.518.119.7
C37-38Other thoracic organs22667.349.646.368.351.649.439.147.1
C40-41Bone34373.553.646.374.154.948.139.239.8
C43Melanoma skin17981.056.448.182.459.652.852.649.5
C44Other skin61891.383.280.093.990.893.293.492.6
C45Mesothelioma5261.544.240.462.546.043.443.840.8
C47+C49Connective tissue48479.561.053.880.663.257.250.855.7
C48Peritoneum16065.646.338.466.547.740.430.441.2
C50Breast535594.082.777.794.584.079.874.478.6
C51Vulva5590.965.560.092.469.266.467.869.3
C52Vagina4682.671.767.283.874.371.162.575.6
C53Cervix535791.379.675.792.081.478.776.279.2
C54Corpus uteri52293.985.281.894.587.084.778.881.7
C55Uterus unspecified8786.277.073.687.078.776.468.777.8
C56Ovary130584.369.364.284.970.766.257.862.2
C57Other female genital8557.645.941.258.247.343.238.940.1
C58Placenta11396.594.792.896.695.093.395.395.3
C60Penis4388.476.764.992.087.982.285.877.5
C61Prostate94885.464.053.590.376.372.874.470.2
C62Testis10696.292.591.596.693.793.794.993.9
C64Kidney117780.667.963.082.171.668.963.570.3
C65Renal pelvis14784.470.765.186.376.474.977.471.1
C66Ureter10485.660.654.487.865.763.157.557.5
C67Urinary bladder193085.570.764.288.377.975.770.979.5
C68Other urinary organs6454.740.634.157.146.742.842.144.3
C69Eye9386.072.067.786.773.870.562.258.1
C70-72Brain & nervous system116362.942.539.263.443.340.437.138.9
C73Thyroid265795.793.791.696.495.694.792.894.4
C74Adrenal gland8767.846.040.868.246.641.723.131.6
C75Other endocrine7880.864.162.781.765.664.737.750.4
C81Hodgkin lymphoma13385.775.271.286.577.174.475.376.3
C82-85+C96Non-Hodgkin lymphoma168071.357.453.572.359.657.056.758.0
C90Multiple myeloma34765.138.327.466.440.630.129.432.0
C91Lymphoid leukaemia59567.146.441.867.446.842.533.838.5
C92-94Myeloid leukaemia121954.531.825.854.932.526.622.726.3
C95Leukaemia unspecified8028.817.514.829.218.115.313.816.8


Graphs:


Other tables available for this registry:
- Table1: Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site (Seoul, South Korea, 1993-1997 cases followed-up until 2001)
- Table2b: Number and proportion of cases by vital status and median follow-up (in months) by site (Seoul, South Korea, 1993-1997 cases followed-up until 2001)
- Table3: Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site (Seoul, South Korea, 1993-1997 cases followed-up until 2001)
- Table4: Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group (Seoul, South Korea, 1993-1997 cases followed-up until 2001)




Registry chapter:


Consult the chapter in Cancer survival in developping countries (Volume II)